Sma: Roche's SMA drug 15x costlier in India than in China & Pak | India News
India News: MUMBAI: Global pharma giant Roche's critical rare disease drug in India costs up to 15 times more than neighbouring China and Pakistan.
Stay updated with breaking news from Roche India. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
India News: MUMBAI: Global pharma giant Roche's critical rare disease drug in India costs up to 15 times more than neighbouring China and Pakistan.
It simplifies access to Roche India's cancer support programme.
The Business Research Company’s Gastrointestinal Drugs Market 2022 - Opportunities And Strategies – Global Forecast To 2030
Regulators have put different COVID-19 treatments through different degrees of scrutiny, with some relatively safe treatments getting short ...
The Punjab government gave statement saying that ‘the partnership will focus on efforts to ensure timely identification, treatment initiation, and ‘robust referral pathways across the various health centres through technology enabled digital live patient tracking support.’ Followed by a statement by the HFW Minister Dr Vijay Singla that the public-private partnership is a significant step…